Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kodiak Sciences (KOD) Research & Development (2017 - 2026)

Kodiak Sciences filings provide 10 years of Research & Development readings, the most recent being $48.5 million for Q1 2026.

  • Quarterly Research & Development rose 11.23% to $48.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $187.3 million through Mar 2026, up 33.95% year-over-year, with the annual reading at $182.4 million for FY2025, 44.63% up from the prior year.
  • Research & Development hit $48.5 million in Q1 2026 for Kodiak Sciences, up from $45.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $76.2 million in Q1 2022 and bottomed at $29.9 million in Q1 2024.
  • Average Research & Development over 5 years is $48.9 million, with a median of $46.6 million recorded in 2023.
  • The largest annual shift saw Research & Development soared 88.85% in 2022 before it crashed 51.44% in 2024.
  • Kodiak Sciences' Research & Development stood at $56.0 million in 2022, then dropped by 16.73% to $46.6 million in 2023, then plummeted by 31.86% to $31.8 million in 2024, then soared by 43.19% to $45.5 million in 2025, then grew by 6.71% to $48.5 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's Research & Development are $48.5 million (Q1 2026), $45.5 million (Q4 2025), and $50.5 million (Q3 2025).